Abstract
Virus-mediated gene delivery has been, to date, the most successful and efficient method for gene therapy. However, this method has been challenged because of serious safety concerns. Over the past decade, mesoporous silica nanoparticles (MSNs) have attracted much attention for intracellular delivery of nucleic acids. Delivery of cellular plasmid DNA (pDNA) is designed to replace the function of a defective gene and restore its normal function in the cell. Delivery of small interfering RNAs (siRNAs) can selectively knockdown genes by targeting specific mRNAs. The biocompatibility and unique structures of MSNs make these nanoparticles ideal candidates to act as biomolecule carriers. This concise review highlights current progress in the field of nucleic acid delivery using MSNs, specifically for delivery of pDNA, siRNA, and combinatorial delivery of nucleic acids and drugs. The review describes important design parameters presently being applied to MSNs to administer drugs and therapeutic nucleic acids.
Similar content being viewed by others
References
Slowing, I. I., Trewyn, B. G., Giri, S., and Lin, V. S.-Y. (2007) Mesoporous silica nanoparticles for drug delivery and biosensing applications, Adv. Funct. Mater., 17, 1225–1236.
Vogt, C., Toprak, M. S., Muhammed, M., Laurent, S., Bridot, J.-L., and Muller, R. N. (2009) High quality and tuneable silica shell–magnetic core nanoparticles, J. Nanopart. Res., 12, 1137–1147.
Tang, L., and Cheng, J. (2013) Nonporous silica nanoparticles for nanomedicine application, Nano Today, 8, 290–312.
Liberman, A., Mendez, N., Trogler, W. C., and Kummel, A. C. (2014) Synthesis and surface functionalization of silica nanoparticles for nanomedicine, Surf. Sci. Rep., 69, 132–158.
Bharti, C., Nagaich, U., Pal, A. K., and Gulati, N. (2015) Mesoporous silica nanoparticles in target drug delivery system: a review, Int. J. Pharm. Invest., 5, 124–133.
Heidegger, S., Gossl, D., Schmidt, A., Niedermayer, S., Argyo, C., Endres, S., and Bourquin, C. (2015) Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery, Nanoscale, 8, 938–948.
Tang, F., Li, L., and Chen, D. (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery, Adv. Mater., 24, 1504–1534.
Wu, S.-H., Hung, Y., and Mou, C.-Y. (2011) Mesoporous silica nanoparticles as nanocarriers, Chem. Commun., 47, 9972–9985.
Wu, S.-H., Mou, C.-Y., and Lin, H.-P. (2013) Synthesis of mesoporous silica nanoparticles, Chem. Soc. Rev., 42, 3862–3875.
Slowing, I. I., Vivero-Escoto, J. L., Wu, C.-W., and Lin, V. S.-Y. (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers, Adv. Drug Deliv. Rev., 60, 1278–1288.
Wang, Y., Zhao, Q., Han, N., Bai, L., Li, J., Liu, J., and Wang, S. (2015) Mesoporous silica nanoparticles in drug delivery and biomedical applications, Nanomed. Nanotechnol. Biol. Med., 11, 313–327.
Li, Q.-L., Xu, S.-H., Zhou, H., Wang, X., Dong, B., Gao, H., and Yang, Y.-W. (2015) pH and glutathione dualresponsive dynamic cross-linked supramolecular network on mesoporous silica nanoparticles for controlled anticancer drug release, ACS Appl. Mater. Interfaces, 7, 28656–28664.
Sun, L., Liu, Y.-J., Yang, Z.-Z., and Qi, X.-R. (2015) Tumor specific delivery with redox-triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization, RSC Adv., 5, 55566–55578.
Zhao, N., Lin, X., Zhang, Q., Ji, Z., and Xu, F.-J. (2015) Redox-triggered gatekeeper-enveloped starlike hollow silica nanoparticles for intelligent delivery systems, Small, 11, 6467–6479.
Yoshitomi, T., and Nagasaki, Y. (2015) Development of silica-containing redox nanoparticles for medical applications, Biomater. Sci., 3, 810–815.
Song, N., and Yang, Y.-W. (2015) Molecular and supramolecular switches on mesoporous silica nanoparticles, Chem. Soc. Rev., 44, 3474–3504.
Shahabi, S., Doscher, S., Bollhorst, T., Treccani, L., Maas, M., Dringen, R., and Rezwan, K. (2015) Enhancing cellular uptake and doxorubicin delivery of mesoporous silica nanoparticles via surface functionalization: effects of serum, ACS Appl. Mater. Interfaces, 7, 26880–26891.
Gabizon, A., Shmeeda, H., and Grenader, T. (2012) Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy, Eur. J. Pharm. Sci., 45, 388–398.
Giménez, C., De la Torre, C., Gorbe, M., Aznar, E., Sancenon, F., Murguia, J. R., and Amoros, P. (2015) Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells, Langmuir, 31, 3753–3762.
Qu, Q., Ma, X., and Zhao, Y. (2015) Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers, Nanoscale, 7, 16677–16686.
Chang, D., Gao, Y., Wang, L., Liu, G., Chen, Y., Wang, T., and Zeng, X. (2015) Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy, J. Coll. Inter. Sci., 463, 279–287.
Lu, J., Liong, M., Zink, J. I., and Tamanoi, F. (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs, Small, 3, 1341–1346.
Mellaerts, R., Jammaer, J. A. G., Van Speybroeck, M., Chen, H., Van Humbeeck, J., Augustijns, P., and Martens, J. A. (2008) Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen, Langmuir, 24, 8651–8659.
Van Speybroeck, M., Barillaro, V., Thi, T. Do, Mellaerts, R., Martens, J., Van Humbeeck, J., and Augustijns, P. (2009) Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs, J. Pharm. Sci., 98, 2648–2658.
Wang, H., Agarwal, P., Zhao, S., Yu, J., Lu, X., and He, X. (2015) A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of therasnostic agents, Nat. Commun., 6, 10081.
Taratula, O., Garbuzenko, O. B., Chen, A. M., and Minko, T. (2011) Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA, J. Drug Target., 19, 900–914.
Mamaeva, V., Sahlgren, C., and Linden, M. (2013) Mesoporous silica nanoparticles in medicine–recent advances, Adv. Drug Deliver. Rev., 65, 689–702.
Li, Z., Barnes, J. C., Bosoy, A., Stoddart, J. F., and Zink, J. I. (2012) Mesoporous silica nanoparticles in biomedical applications, Chem. Soc. Rev., 41, 2590–2605.
Baeza, A., Colilla, M., and Vallet-Regi, M. (2015) Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery, Expert Opin. Drug Deliv., 12, 319–337.
Radu, D. R., Lai, C.-Y., Jeftinija, K., Rowe, E. W., Jeftinija, S., and Lin, V. S.-Y. (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent, J. Am. Chem. Soc., 126, 13216–13217.
Park, I. Y., Kim, I. Y., Yoo, M. K., Choi, Y. J., Cho, M.-H., and Cho, C. S. (2008) Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptormediated gene delivery, Int. J. Pharm., 359, 280–287.
Qin, F., Zhou, Y., Shi, J., and Zhang, Y. (2009) A DNA transporter based on mesoporous silica nanospheres mediated with polycation poly(allylamine hydrochloride) coating on mesopore surface, J. Biomed. Mater. Res. Part A, 90, 333–338.
Kim, T.-H., Kim, M., Eltohamy, M., Yun, Y.-R., Jang, J.-H., and Kim, H.-W. (2013) Efficacy of mesoporous silica nanoparticles in delivering BMP-2 plasmid DNA for in vitro osteogenic stimulation of mesenchymal stem cells, J. Biomed. Mater. Res. Part A, 101, 1651–1660.
Dengler, E. C., Liu, J., Kerwin, A., Torres, S., Olcott, C. M., Bowman, B. N., and Milligan, E. D. (2013) Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord, J. Control. Rel., 168, 209–224.
Brevet, D., Hocine, O., Delalande, A., Raehm, L., Charnay, C., Midoux, P., and Pichon, C. (2014) Improved gene transfer with histidine-functionalized mesoporous silica nanoparticles, Int. J. Pharm., 471, 197–205.
Gao, F., Botella, P., Corma, A., Blesa, J., and Dong, L. (2009) Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA, J. Phys. Chem., 113, 1796–1804.
Kim, M.-H., Na, H.-K., Kim, Y.-K., Ryoo, S.-R., Cho, H. S., Lee, K. E., and Min, D.-H. (2011) Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery, ACS Nano, 5, 3568–3576.
Hom, C., Lu, J., Liong, M., Luo, H., Li, Z., Zink, J. I., and Tamanoi, F. (2010) Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells, Small, 6, 1185–1190.
Ashley, C. E., Carnes, E. C., Epler, K. E., Padilla, D. P., Phillips, G. K., Castillo, R. E., and Brinker, C. J. (2012) Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers, ACS Nano, 6, 2174–2188.
Na, H.-K., Kim, M.-H., Park, K., Ryoo, S.-R., Lee, K. E., Jeon, H., and Min, D.-H. (2012) Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores, Small, 8, 1752–1761.
Zhang, L., Wang, T., Li, L., Wang, C., Su, Z., and Li, J. (2012) Multifunctional fluorescent-magnetic polyethyleneimine functionalized Fe3O4-mesoporous silica yolkshell nanocapsules for siRNA delivery, Chem. Commun., 48, 8706–8708.
Hartono, S. B., Gu, W., Kleitz, F., Liu, J., He, L., Middelberg, A. P. J., and Qiao, S. Z. (2012) Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery, ACS Nano, 6, 2104–2117.
Li, X., Chen, Y., Wang, M., Ma, Y., Xia, W., and Gu, H. (2013) A mesoporous silica nanoparticle–PEI–fusogenic peptide system for siRNA delivery in cancer therapy, Biomaterials, 34, 1391–1401.
Wang, M., Li, X., Ma, Y., and Gu, H. (2013) Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery, Int. J. Pharm., 448, 51–57.
Lin, D., Cheng, Q., Jiang, Q., Huang, Y., Yang, Z., Han, S., and Dong, A. (2013) Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo, Nanoscale, 5, 4291–4301.
Shen, J., Kim, H. C., Su, H., Wang, F., Wolfram, J., Kirui, D., and Shen, H. (2014) Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics, Theranostics, 4, 487–497.
Du, X., Xiong, L., Dai, S., Kleitz, F., and Qiao, S. Z. (2014) Intracellular microenvironment-responsive dendrimer-like mesoporous nanohybrids for traceable, effective, and safe gene delivery, Adv. Funct. Mater., 24, 7627–7637.
Chen, Y., Gu, H., Zhang, D. S.-Z., Li, F., Liu, T., and Xia, W. (2014) Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier, Biomaterials, 35, 10058–10069.
Hartono, S. B., Yu, M., Gu, W., Yang, J., Strounina, E., Wang, X., and Yu, C. (2014) Synthesis of multi-functional large pore mesoporous silica nanoparticles as gene carriers, Nanotechnology, 25, 055701.
Finlay, J., Roberts, C. M., Dong, J., Zink, J. I., Tamanoi, F., and Glackin, C. A. (2015) Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden, Nanomed. Nanotechnol., 11, 1657–1666.
Xiong, L., Bi, J., Tang, Y., and Qiao, S.-Z. (2016) Magnetic core-shell silica nanoparticles with large radial mesopores for siRNA delivery, Small, 12, 4735–4742.
Moller, K., Muller, K., Engelke, H., Brauchle, C., Wagner, E., Bein, T., and Brauchle, C. (2016) Highly efficient siRNA delivery from core-shell mesoporous silica nanoparticles with multifunctional polymer caps, Nanoscale, 8, 4007–4019.
Bhattarai, S. R., Muthuswamy, E., Wani, A., Brichacek, M., Castaсeda, A. L., Brock, S. L., and Oupicky, D. (2010) Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine, Pharm. Res., 27, 2556–2568.
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., and He, H. (2009) Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells, Small, 5, 2673–2677.
Ma, X., Teh, C., Zhang, Q., Borah, P., Choong, C., Korzh, V., and Zhao, Y. (2014) Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin, Antioxid. Redox Signal., 21, 707–722.
Ma, X., Zhao, Y., Ng, K. W., and Zhao, Y. (2013) Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery, Chemistry, 19, 15593–15603.
Zhou, X., Chen, L., Nie, W., Wang, W., Qin, M., Mo, X., and He, C. (2016) Dual-responsive mesoporous silica nanoparticles mediated codelivery of doxorubicin and Bcl-2 siRNA for targeted treatment of breast cancer, J. Phys. Chem. C, 120, 22375–22387.
Meng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., and Nel, A. E. (2010) Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line, ACS Nano, 4, 4539–4550.
Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., and Nel, A. E. (2013) Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo, ACS Nano, 7, 994–1005.
Kar, M., Tiwari, N., Tiwari, M., Lahiri, M., and Gupta, S. S. (2013) Poly-L-arginine grafted silica mesoporous nanoparticles for enhanced cellular uptake and their application in DNA delivery and controlled drug release, Particle Particle Systems Charact., 30, 166–179.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2017, Vol. 82, No. 6, pp. 873-882.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM16-409, March 6, 2017.
Rights and permissions
About this article
Cite this article
Keasberry, N.A., Yapp, C.W. & Idris, A. Mesoporous silica nanoparticles as a carrier platform for intracellular delivery of nucleic acids. Biochemistry Moscow 82, 655–662 (2017). https://doi.org/10.1134/S0006297917060025
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297917060025